JPRN-jRCTs051180073进行中（未招募）未知
Treatment of alopecia areata with oral tacrolimus - Treatment of alopecia areata with oral tacrolimus
Dainichi Teruki0 个研究点目标入组 10 人开始时间: 2019年2月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 50age old（—）
- 性别
- All
入选标准
- •Confirmation of the diagnosis
- •Acute cases:
- •25% or more hair loss in 3 months or less for the first time
- •Chronic cases:
- •25% or more hair loss for 6 months or more; uncontrolled by existing treatments
排除标准
- •Heart, kidney, or endocrine disorders
- •Infectious diseases: viral hepatitis, tuberculosis, syphilis, pneumonia, urinary tract infections
- •Mental diseases
- •Current or past cancers
- •Current or possible pregnancy
- •Others considered by doctors
- •Contraindication of oral tacrolimus
研究者
相似试验
已完成
不适用
Treatment of alopecia areata with oral tacrolimusAlopecia areataJPRN-UMIN000030610Kyoto University Hospital10
进行中（未招募）
不适用
Treatment of therapy resistant Alopecia areata with fumaric acid esters (Fumaderm® and Fumaderm initial®) – an open, single center, non-randomized, pilot study with 40 patientsAlopecia areataMedDRA version: 14.1Level: PTClassification code 10001761Term: Alopecia areataSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2011-000659-18-DEniversity Hospital Tübingen
进行中（未招募）
不适用
Topische Anwendung von Tacrolimus (Protopic) bei verschiedenen Formen des kutanen Lupus erythe-matodes im Rahmen einer klinischen Untersuchung an mehreren nationalen Zentren - entfälltEUCTR2004-005020-41-DEHeinrich Heine Universität Düsseldorf30
已完成
1 期
Safety and efficacy of topical tacrolimus therapy for refractory pouchitispouchitisJPRN-UMIN000006658Department of lower gastroenterological surgery, Hyogo college of Medicine10
已完成
1 期
A pharmacological study of tacrolimus ointmentAtopic dermatitisJPRN-jRCT1080225219Maruho Co.,Ltd.20